Eva Berent

772 total citations
19 papers, 663 citations indexed

About

Eva Berent is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Eva Berent has authored 19 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Eva Berent's work include Computational Drug Discovery Methods (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Tryptophan and brain disorders (3 papers). Eva Berent is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Tryptophan and brain disorders (3 papers). Eva Berent collaborates with scholars based in Israel, United States and Germany. Eva Berent's co-authors include Etta Livneh, Yael Yuhas, Shai Ashkenazi, Joseph Schlessinger, A Ullrich, Ron Prywes, Thomas J. Dull, Nachum Reiss, Ada Rozen and Abraham Weizman and has published in prestigious journals such as The EMBO Journal, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Eva Berent

18 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Berent Israel 13 481 121 77 62 47 19 663
Silvia M. Sanz‐González Spain 13 504 1.0× 115 1.0× 73 0.9× 83 1.3× 46 1.0× 36 891
Hong-Duck Um South Korea 12 486 1.0× 141 1.2× 62 0.8× 62 1.0× 65 1.4× 17 712
Kozo Ishidate Japan 16 500 1.0× 85 0.7× 83 1.1× 57 0.9× 38 0.8× 29 754
Lele Li China 15 227 0.5× 121 1.0× 55 0.7× 46 0.7× 37 0.8× 33 540
Ying Cheng China 13 346 0.7× 127 1.0× 27 0.4× 30 0.5× 63 1.3× 33 716
Jiaxiang Chen China 15 388 0.8× 100 0.8× 62 0.8× 18 0.3× 43 0.9× 33 623
Tiziana Di Matola Italy 18 394 0.8× 91 0.8× 53 0.7× 19 0.3× 44 0.9× 32 848
Hisanori Miki Japan 12 463 1.0× 148 1.2× 48 0.6× 41 0.7× 141 3.0× 41 793
Steve L. Abrams United States 5 444 0.9× 135 1.1× 42 0.5× 14 0.2× 38 0.8× 8 625
Mariarosa Perotti Italy 8 268 0.6× 47 0.4× 34 0.4× 63 1.0× 25 0.5× 16 495

Countries citing papers authored by Eva Berent

Since Specialization
Citations

This map shows the geographic impact of Eva Berent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Berent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Berent more than expected).

Fields of papers citing papers by Eva Berent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Berent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Berent. The network helps show where Eva Berent may publish in the future.

Co-authorship network of co-authors of Eva Berent

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Berent. A scholar is included among the top collaborators of Eva Berent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Berent. Eva Berent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Yuhas, Yael, Shai Ashkenazi, Eva Berent, & Abraham Weizman. (2022). Clozapine Suppresses the Gene Expression and the Production of Cytokines and Up-Regulates Cyclooxygenase 2 mRNA in Human Astroglial Cells. Brain Sciences. 12(12). 1703–1703. 7 indexed citations
3.
Ashkenazi‐Hoffnung, Liat, Gilat Livni, Oded Scheuerman, et al.. (2021). Differential Serum and Urine CRP, IP-10, and TRAIL Levels in Pediatric Urinary Tract Infection. Frontiers in Pediatrics. 9. 771118–771118. 8 indexed citations
4.
Khazanov, Netaly, Eva Berent, Daniele Marciano, et al.. (2020). Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site. International Journal of Molecular Sciences. 21(22). 8709–8709. 18 indexed citations
5.
Yuhas, Yael, Shai Ashkenazi, Eva Berent, & Abraham Weizman. (2017). Ketamine upregulates eNOS expression in human astroglial A172 cells: Possible role in its antidepressive properties. Journal of Neuroimmunology. 305. 75–81. 5 indexed citations
6.
Yuhas, Yael, Shai Ashkenazi, Eva Berent, & Abraham Weizman. (2015). Immunomodulatory activity of ketamine in human astroglial A172 cells: Possible relevance to its rapid antidepressant activity. Journal of Neuroimmunology. 282. 33–38. 20 indexed citations
7.
Yarden‐Bilavsky, Havatzelet, Ella Mendelson, Yael Yuhas, et al.. (2014). Apnea Induced by Respiratory Syncytial Virus Infection is not Associated with Viral Invasion of the Central Nervous System. The Pediatric Infectious Disease Journal. 33(8). 880–881. 11 indexed citations
8.
Yuhas, Yael, Eva Berent, & Shai Ashkenazi. (2014). Effect of nitric oxide on microRNA-155 expression in human hepatic epithelial cells. Inflammation Research. 63(7). 591–596. 12 indexed citations
9.
Yuhas, Yael, Eva Berent, & Shai Ashkenazi. (2011). Effect of Rifampin on Production of Inflammatory Mediators in HepG2 Liver Epithelial Cells. Antimicrobial Agents and Chemotherapy. 55(12). 5541–5546. 20 indexed citations
10.
Yuhas, Yael, Eva Berent, Regev Cohen, & Shai Ashkenazi. (2008). Roles of NF-κB Activation and Peroxisome Proliferator-Activated Receptor Gamma Inhibition in the Effect of Rifampin on Inducible Nitric Oxide Synthase Transcription in Human Lung Epithelial Cells. Antimicrobial Agents and Chemotherapy. 53(4). 1539–1545. 14 indexed citations
11.
Yuhas, Yael, Inbar Azoulay‐Alfaguter, Eva Berent, & Shai Ashkenazi. (2007). Rifampin Inhibits Prostaglandin E2Production and Arachidonic Acid Release in Human Alveolar Epithelial Cells. Antimicrobial Agents and Chemotherapy. 51(12). 4225–4230. 21 indexed citations
12.
Yuhas, Yael, et al.. (2005). Rifampin Augments Cytokine-Induced Nitric Oxide Production in Human Alveolar Epithelial Cells. Antimicrobial Agents and Chemotherapy. 50(1). 396–398. 19 indexed citations
13.
Mor, Orna, Ofer Nativ, Avi Stein, et al.. (2003). Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene. 22(48). 7702–7710. 42 indexed citations
14.
Kotlo, Kumar, Elena V. Efimova, Ksenya Shchors, et al.. (2003). Nrf2 is an inhibitor of the Fas pathway as identified by Achilles' Heel Method, a new function-based approach to gene identification in human cells. Oncogene. 22(6). 797–806. 66 indexed citations
15.
Berent, Eva, et al.. (1991). Isolation and Characterization of PKC-L, A New Member of the Protein Kinase C-Related Gene Family Specifically Expressed in Lung, Skin, and Heart. Molecular and Cellular Biology. 11(1). 126–133. 41 indexed citations
16.
Berent, Eva, et al.. (1991). Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart.. Molecular and Cellular Biology. 11(1). 126–133. 191 indexed citations
17.
Livneh, Etta, Thomas J. Dull, Eva Berent, et al.. (1988). Release of a Phorbol Ester-Induced Mitogenic Block by Mutation at Thr-654 of the Epidermal Growth Factor Receptor. Molecular and Cellular Biology. 8(6). 2302–2308. 24 indexed citations
18.
Livneh, Etta, Thomas J. Dull, Eva Berent, et al.. (1988). Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor.. Molecular and Cellular Biology. 8(6). 2302–2308. 73 indexed citations
19.
Livneh, Etta, Nachum Reiss, Eva Berent, A Ullrich, & Joseph Schlessinger. (1987). An insertional mutant of epidermal growth factor receptor allows dissection of diverse receptor functions.. The EMBO Journal. 6(9). 2669–2676. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026